Medication Development in Alcoholism: Investigating PPAR Agonists

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Alcoholism
Interventions
DRUG

Sugar Pill

145 mg/day, oral pill, 9 days

DRUG

TRICOR (fenofibrate)

145 mg/day, oral pill, 9 days

Trial Locations (1)

92037

Susan Quello, La Jolla

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

The Scripps Research Institute

OTHER

NCT02158273 - Medication Development in Alcoholism: Investigating PPAR Agonists | Biotech Hunter | Biotech Hunter